Predictive test for personalised anti-tumor treatment
Log in
Forgot your password?
Open account
fr
en
0
0
View cart
Who are we ?
Technology
Diagnostic
Pharma/Biotech
CRO services
Publications
Partners
FAQ
Contact
Predictive test for personalised anti-tumor treatment
Exhibitions and events
List of headings :
Upcoming webinars
OncoTarget : signature of the exclusive licence - 23.05.2023
Personalised medicine • Oncology • Next-generation sequencing-NGS • Diagnostic • • Biotechnology • Bioinformatics • Innovation • Technology transfer
Partnership between Eurofins Biomnis and Oncomedics
Oncomedics - Oncomedics Group - is pleased to announce its partnership with Eurofins Biomnis, European leader in specialized medical biology.
Press release : Oncomedics joins Oncomedics Group
Oncomedics Group, a European distributor of reagents and equipment for scientific research and medical diagnosis, has acquired Oncomedics, a French biotechnology company specialising in the personalisation of cancer treatments.